Vamotinib
Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis. Vamotinib is used to study drug-resistant Philadelphia chromosome-positive (Ph+) leukaemia and Alzheimer's disease.
Product Specifications
CAS Number
1416241-23-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.56
Molecular Formula
C29H27F3N6O
Notes
Research use only, not for human use.
Receptor
Bcr-Abl | Apoptosis | Tyrosine Kinases
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TR306049 1 Kit
PPPDE1 (DESI2) Human shRNA Plasmid Kit (Locus ID 51029)
Sign In for Pricing
View Details 
KRT19-1265H 50 µg
Recombinant Human KRT19 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
MBS1294235 Inquire
Recombinant Rat Dual serine/threonine and tyrosine protein kinase (Dstyk) , partial
Sign In for Pricing
View Details